IRB Infrastructure Developers Completed 2,351cr Capital Through its Sponsored IRB InvIT Fund.
"IRB InvIT Fund has successfully completed its rupee 2,351 crore fundraise."
IRB InvIT Fund Completes Fundraise
IRB Infrastructure Developers has completed a rupee 2,351 crore capital raise through its sponsored IRB InvIT Fund. The fundraise includes rupee 2,000 crore raised through a QIP and another rupee 351 crore through a preferential allotment of units.
The fundraise received participation from domestic and international institutional investors, providing the InvIT with additional capital for its asset acquisition and expansion plans.
Fundraise Details
- Total Fundraise: rupee 2,351 crore
- QIP: rupee 2,000 crore
- Preferential Allotment: rupee 351 crore
- Parent Contribution: rupee 351 crore by IRB Infrastructure Developers
- Investor Participation: Domestic and international institutional investors
What to Watch Next
Investors may track the completion of the BOT asset acquisitions, deployment of the fundraise and the InvIT's new highway project pipeline. The pace of asset additions and future fund-raising activity could also remain key developments.
Disclaimer
Investments in the securities market are subject to market risks. Read all related documents carefully before investing. Registration granted by SEBI, and certification from NISM in no way guarantee the performance of the intermediary or provide any assurance of returns to investors. Choice Equity Broking Private Limited: SEBI Reg No. Broking - INZ000160131 ( BSE - 3299 ) | ( NSE - 13773 ) | ( MSEI - 73200 ) | ( MCX - 40585 ) | ( NCDEX - 01006 ). Depository Participant SEBI Reg. No. - IN - DP - 84 - 2015, DP ID CDSL - 12066900, NSDL ID - IN301895. Research Analyst - INH000000222 (CIN. NO.: U65999MH2010PTC198714)
Other News
Sharp Investments Proposes Preferential Issue Through Share Swap
Sharp Investments Limited has proposed a preferential allotment of up to 27.52 crore equity shares at Rs.1 each to non-promoter entities as consideration for acquiring a 100% stake in Rajal Lefin & Commercial Private Limited (RLCPL) through a share swap.
Lupin Gets U.S. FDA Tentative Approval for Apixaban Oral Suspension
Lupin Limited has received tentative approval from the U.S. FDA for its Apixaban Oral Suspension 1.25 mg/mL, an oral liquid formulation of apixaban intended for patients requiring anticoagulation treatment.
Kalpataru Projects Wins Major UAE Gas Pipeline EPC Order
Kalpataru Projects International Limited (KPIL) has secured a major Engineering, Procurement and Construction (EPC) order for a gas pipeline project in the United Arab Emirates (UAE). The company received a Letter of Award (LoA) for the EPC contract, with the order classified as 'Major' and estimated to be valued at over Rs.4,000 crore. KPIL said the order reinforces its capabilities and track record in the global Oil and Gas sector.